Pharma
Digitally-enabled pharmacotherapy, theragnostics, and mental health endpoints.
The greatest challenges facing the pharmaceutical industry today include changing patient expectations, increased self-medication, difficulties in identifying novel medicines for incurable diseases, high payer scrutiny of pharma-economic performance, the trend for governments to favour prevention over treatment, and access to emerging markets. Partnering with MI helps turn these challenges into opportunities.
What we offer
✓ Development of clinical psychotherapy interventions for multiple indications and comorbidities
✓ Intervention delivery at scale via an engaging mobile platform
✓ Objective quantification of efficacy and mental wellbeing in real time, without the need for a wearable
Rx + DTx pairing
Improve efficacy & patient experience
Accelerate market access & reimbursement
Standalone DTx
Generate compound-agnostic revenue
Access actionable patient data
Clinical endpoints
Capture objective biometrics remotely
Augment mental wellbeing assessment
